Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers.
暂无分享,去创建一个
Raúl San José Estépar | Linfu Zhou | Rola Harmouche | Raul San Jose Estepar | Thomas P. Young | François Maltais | J. Hokanson | G. Washko | J. Ross | A. Díaz | F. Maltais | G. Kinney | E. Wouters | H. Coxson | W. MacNee | S. Rennard | M. McDonald | R. Harmouche | William MacNee | Stephen Rennard | Linfu Zhou | Merry-Lynn McDonald | George R. Washko | Alejandro A. Diaz | Tom P. Young | James C. Ross | Emiel F.M. Wouters | Harvey O. Coxson | Gregory L. Kinney | John E. Hokanson | W. Macnee | Merry-Lynn N. McDonald
[1] F. Maltais,et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD , 2010, BMC pulmonary medicine.
[2] K. Joshi,et al. Evaluation of HS-CRP and Lipid Profile in COPD. , 2013, Journal of clinical and diagnostic research : JCDR.
[3] Renata Ferrari,et al. Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease , 2013, Respiratory Research.
[4] B. Nordestgaard,et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. , 2013, JAMA.
[5] L. Edwards,et al. CT‐measured bone attenuation in patients with chronic obstructive pulmonary disease: Relation to clinical features and outcomes , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] M. Kovarik,et al. Skinfold Anthropometry –The Accurate Method for Fat Free Mass Measurement in COPD , 2013, COPD.
[7] Raúl San José Estépar,et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. , 2014, Annals of the American Thoracic Society.
[8] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[9] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.
[10] Sally J. Singh,et al. Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.
[11] R. Casaburi,et al. Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease: Do They Influence Patient-Related Outcomes? , 2013, Annals of Nutrition and Metabolism.
[12] Y. Kang,et al. Body mass index and fat free mass index in obstructive lung disease in Korea. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] D. Mannino,et al. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. , 2013, Chest.
[14] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[16] S. Keinänen-Kiukaanniemi,et al. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. , 2008, American journal of preventive medicine.
[17] Y. Lacasse,et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[18] D. Mannino,et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease , 2012, Thorax.
[19] E. Wouters,et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. , 2011, Respiratory medicine.
[20] S. Bojesen,et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[21] George R Washko,et al. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. , 2013, Respiratory medicine.
[22] W. MacNee,et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.
[23] J. Murabito,et al. Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.
[24] G. Wesseling,et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. , 2011, The American journal of clinical nutrition.
[25] D. Mannino,et al. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.
[26] J Moxham,et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD , 2009, Thorax.
[27] L. Edwards,et al. Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.
[28] E. Wouters,et al. Body composition and mortality in chronic obstructive pulmonary disease. , 2005, American Journal of Clinical Nutrition.